Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eben

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Der Orthopade|January 30, 2008
[Allergy to bone cement components]P Thomas, A Schuh, R Eben, et al.
Der Orthopade|May 27, 2009
[Implant allergy register--a first report]R Eben, R Walk, B Summer, et al.
Deutsche Medizinische Wochenschrift (1946)|July 9, 2010
[Contact allergy to metals and bone cement components in patients with intolerance of arthroplasty]R Eben, K-A Dietrich, C Nerz, et al.
The British Journal of Dermatology|September 30, 2009
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trialK Hartmann, F Siebenhaar, B Belloni, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Der Orthopade|January 30, 2008
[Allergy to bone cement components]P Thomas, A Schuh, R Eben, et al.
Der Orthopade|May 27, 2009
[Implant allergy register--a first report]R Eben, R Walk, B Summer, et al.
Deutsche Medizinische Wochenschrift (1946)|July 9, 2010
[Contact allergy to metals and bone cement components in patients with intolerance of arthroplasty]R Eben, K-A Dietrich, C Nerz, et al.
The British Journal of Dermatology|September 30, 2009
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trialK Hartmann, F Siebenhaar, B Belloni, et al.
Pageof 1